1. Click here to sign the "Publish the NICE ME/CFS Guideline Now" petition.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 13th September 2021 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Long-term sequelae of sporadic cryptosporidiosis: a follow-up study

Discussion in 'BioMedical ME/CFS Research' started by Dolphin, May 10, 2018.

  1. Dolphin

    Dolphin Senior Member (Voting Rights)

    Messages:
    3,086
    Another infection that leads to long-term symptoms including fatigue. I hope they follow-up patients again at a later stage.

    Free full text:

    https://link.springer.com/article/10.1007/s10096-018-3268-9

    European Journal of Clinical Microbiology & Infectious Diseases

    pp 1–8| Cite as

    Long-term sequelae of sporadic cryptosporidiosis: a follow-up study
    • Zsófia IglóiEmail author
    • L. Mughini-Gras
    • L. Nic Lochlainn
    • A. Barrasa
    • J. Sane
    • S. Mooij
    • B. Schimmer
    • J. Roelfsema
    • W. van Pelt
    • T. Kortbeek
    Open Access
    Original Article
    First Online: 05 May 2018
    • 77Downloads
    Abstract
    To determine the frequency of occurrence of sequelae following cryptosporidiosis. A follow-up study was performed during a case-control study for sporadic cryptosporidiosis in the Netherlands (2013–2016). Cryptosporidiosis cases were invited to complete a follow-up questionnaire 4 months after diagnosis. Using a case-crossover study design, we compared the frequencies of reported symptoms 4 months after the acute phase to those reported 4 months before the onset of illness and during illness. Frequencies of symptoms in the pre- to post-infection phases were also compared with those of a population control group. Cryptosporidium species-specific effects were also studied. Logistic regression was used to calculate adjusted odds ratios (aOR) for symptoms occurrence. Of the 731 available cases, 443 (60%) responded and 308 (42%) could be included in the follow-up study. The median age was 26 years (range 1–80); 58% were female; 30% were infected with C. hominis and 70% with C. parvum. Compared to before illness, cases were significantly more likely to report dizziness (OR = 2.25), headache (OR = 2.15), fatigue (OR = 2.04), weight loss (OR = 1.82), diarrhoea (OR = 1.50), abdominal pain (OR = 1.38) or joint pain (OR = 1.84). However, symptoms of joint pain and headache occurred among cases after illness at a rate that was not significantly different from that observed in the general population. There were no significant differences in post-infection symptom occurrence between C. hominis and C. parvum. The disease burden of cryptosporidiosis extends beyond the acute phase of the infection, with cases reporting both intestinal and extra-intestinal symptoms up to 4 months following infection.

    Keywords
    Cryptosporidium hominis Cryptosporidium parvum Case-crossover study Long-term sequela The Netherlands
     
    Last edited: May 10, 2018
    Woolie, Trish and Sean like this.

Share This Page